Rui Jin

Vivace Therapeutics, Inc. discovers and develops novel cancer drug. The company was founded by Shuang Qiao in 2014 and is headquartered in San Mateo, CA.

Part of GNI Group Ltd., Shanghai Genomics, Inc. engages in therapeutic pharmaceutical products development and production. The company is based in Shanghai, China. Shanghai Genomics was acquired by GNI Group Ltd. on June 20, 2005. The Chinese company was founded by Ying Luo, Jun Wu.

Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China.

ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore.

Shanghai Haoyitong Health Info Consulting Co. Ltd. provides Medical technology, communication, system integration, network technology in the field of technology development, technical advice, technical services, technology transfer; computer hardware and software, computer software, communications, systems integration, network technology, technical consulting, technical consulting, business consulting, business consulting, advertising design, production, , Medical equipment wholesale, commission agents, online retail and provide related services. The company was founded on September 27, 2009 and is headquartered in Guangzhou, China.

Shanghai Cenova Biomedicine Venture Capital Invt Co. Ltd. invests in companies located in China. The fund invests in sectors related to biotechnology and health care. It provides financing for start-up and growth stage companies.

Part of WuXi AppTec Co., Ltd., WuXi AppTec (Shanghai) Co. Ltd. develops and manufactures pharmaceuticals. The company is based in Shanghai, China.

Shanghai Lianji Biotechnology Co. Ltd. develops vaccines using recombinant protein and antigen expression systems in yeast. The company is based in Shanghai, China.

Suzhou Jingyi Healthcare Equipment Co., Ltd. was founded in 2011 by Yi Hua Ning and is based in Suzhou, China. The Chinese company is an innovative high-tech medical equipment company that specializes in the research and development, production, and sales of deep brain stimulation systems. The company has complete independent intellectual property rights and are constantly developing new technologies and products. The company's goal is to become a medical equipment company with international high-end technology and competitiveness, allowing more patients to benefit from high-tech medical treatment.

Luqa Ventures Co. Ltd. is a Chinese pharmaceutical manufacturing company. The private company is based in Hong Kong, Hong Kong.

Micropoint Biotechnologies Co., Ltd. engages in the manufacture and sale of medical diagnosis, monitoring, and treatment equipment. Its business scope includes technology development, assembly production, and sale of clinical testing and analysis equipment, biochip, testing equipment, analytical instruments, and laboratory apparatus; development and sale of computer software; self-developed software. The company was founded by Ping Yi Yan on July 26, 2007 and is headquartered in Shenzhen, China.

Part of Cenova Ventures, Alnair Investment is a Caymanian company that provides investment services. The company is based in George Town, Cayman Islands.

Neucyte, Inc. operates as bio technology company focusing on neurological diseases. The firm specializes in drug discovery process by using cell based target-identification and drug-discovery platforms. The company was founded by Daniel Haag, Thomas C. Sudhof, Jonathan Davila, and Tao Huang in 2015 and is headquartered in Mountain View, CA.

Novoasis Investment Ltd. provides investment services. The private company is based in Hong Kong, Hong Kong.

Shanghai Birdie Biotech Ltd. is a private company that specializes in biotechnology research and development. The company is based in Shanghai, China.

Etongonline Shanghai Medical Consulting Co. Ltd. provides third-party health management services. The private company is based in Shanghai, China.

Jing Medicine Technology Shanghai Ltd. develops therapeutic monoclonal antibody and small molecule drugs. The private company is based in Shanghai, China.

Choice Technology, Inc. is a company based in Hangzhou, China. Choice Technology specializes in micro-pulse mall maintenance. The Chinese company was founded in 2013 by Jia Lin Qiu, who has been the CEO since then.

Shanghai Phoebus Medical Technology Co., Ltd. is a provider of chronic disease management solutions, with a focus on monitoring diabetic retinopathy. The company is based in Shanghai, China. The Chinese company uses data to promote collaboration between medical institutions and offers comprehensive services for screening, monitoring, education, and follow-up to help reduce the risk of complications for diabetes and hypertension patients. The company was founded by Yun Wang.

Cheng Heng Health Science & Technology Holdings Ltd. is an investment holding Caymanian company. The private company is based in George Town, Cayman Islands.

Hk Doctorlink Internet Tech Co. Ltd. provides network technology services. The private company is based in Hong Kong, Hong Kong.

Virtuoso Therapeutics, Inc. is an oncology-focused small molecule drug discovery and development company. The company is headquartered in San Mateo, CA.

AceLink Therapeutics, Inc. is a biopharmaceutical startup founded in 2018 that focuses on developing safe and effective medicines to address genetic diseases with high unmet needs. AceLink Therapeutics is based in Newark, CA. The private company's initial focus is on developing novel therapeutics for Fabry disease and type 1 Gaucher disease. The company was founded in 2018 by Wen Chen, Marvin R. Garovoy, and Jerry Shen. Jerry Shen has been the CEO since 2018.